stocksrising
7 minutes ago
Due to the ongoing discussions between the Company and Teoxane, the Company, Crown Laboratories, Inc. (“Crown”) and Reba Merger Sub, Inc. (“Merger Sub,” and together with Crown, the “Buyer Parties”) agreed on October 18, 2024 to further extend the date by which Merger Sub is obligated to commence th